Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
Antiviral Therapy
|
June 25, 2013
Evolution of cell culture systems for HCV
Deborah R Taylor
Vaccine
|
September 30, 2005
Obstacles and advances in SARS vaccine development
Deborah R Taylor
International Journal of Biomedical Science : IJBS
|
May 16, 2013
Overcoming hurdles in hepatitis C virus research: efficient production of infectious virus in cell culture
Erica Silberstein, Deborah R Taylor
Frontiers in Bioscience (Landmark Edition)
|
June 2, 2009
Innate immunity and hepatitis C virus: eluding the host cell defense
Deborah R Taylor, Erica Silberstein
Transfusion
|
September 28, 2006
Evaluation of inactivation methods for severe acute respiratory syndrome coronavirus in noncellular blood products
Miriam E R Darnell, Deborah R Taylor
Journal of Virology
|
January 5, 2002
Detection of a novel unglycosylated form of hepatitis C virus E2 envelope protein that is located in the cytosol and interacts with PKR
Nicole Pavio, Deborah R Taylor, Michael M C Lai
Viral Immunology
|
April 12, 2013
Immunogenicity and protection efficacy of monomeric and trimeric recombinant SARS coronavirus spike protein subunit vaccine candidates
Jie Li, Laura Ulitzky, Erica Silberstein, et al.
Journal of Virology
|
February 19, 2010
Achieving a golden mean: mechanisms by which coronaviruses ensure synthesis of the correct stoichiometric ratios of viral proteins
Ewan P Plant, Rasa Rakauskaite, Deborah R Taylor, et al.
Journal of Virological Methods
|
September 8, 2004
Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV
Miriam E R Darnell, Kanta Subbarao, Stephen M Feinstone, et al.
Archives of Virology
|
July 14, 2012
Biochemical characterization of a recombinant SARS coronavirus nsp12 RNA-dependent RNA polymerase capable of copying viral RNA templates
Dae-Gyun Ahn, Jin-Kyu Choi, Deborah R Taylor, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
Antiviral Therapy
|
June 25, 2013
Evolution of cell culture systems for HCV
Deborah R Taylor
Vaccine
|
September 30, 2005
Obstacles and advances in SARS vaccine development
Deborah R Taylor
International Journal of Biomedical Science : IJBS
|
May 16, 2013
Overcoming hurdles in hepatitis C virus research: efficient production of infectious virus in cell culture
Erica Silberstein, Deborah R Taylor
Frontiers in Bioscience (Landmark Edition)
|
June 2, 2009
Innate immunity and hepatitis C virus: eluding the host cell defense
Deborah R Taylor, Erica Silberstein
Transfusion
|
September 28, 2006
Evaluation of inactivation methods for severe acute respiratory syndrome coronavirus in noncellular blood products
Miriam E R Darnell, Deborah R Taylor
Journal of Virology
|
January 5, 2002
Detection of a novel unglycosylated form of hepatitis C virus E2 envelope protein that is located in the cytosol and interacts with PKR
Nicole Pavio, Deborah R Taylor, Michael M C Lai
Viral Immunology
|
April 12, 2013
Immunogenicity and protection efficacy of monomeric and trimeric recombinant SARS coronavirus spike protein subunit vaccine candidates
Jie Li, Laura Ulitzky, Erica Silberstein, et al.
Journal of Virology
|
February 19, 2010
Achieving a golden mean: mechanisms by which coronaviruses ensure synthesis of the correct stoichiometric ratios of viral proteins
Ewan P Plant, Rasa Rakauskaite, Deborah R Taylor, et al.
Journal of Virological Methods
|
September 8, 2004
Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV
Miriam E R Darnell, Kanta Subbarao, Stephen M Feinstone, et al.
Archives of Virology
|
July 14, 2012
Biochemical characterization of a recombinant SARS coronavirus nsp12 RNA-dependent RNA polymerase capable of copying viral RNA templates
Dae-Gyun Ahn, Jin-Kyu Choi, Deborah R Taylor, et al.
Page
of 3